Openai's Miles Wang Exits to Found $2B AI Drug Startup

WHO:

Techmeme - Miles Wang, an OpenAI researcher, is leaving the company.

TechCrunch - Miles Wang is associated with OpenAI, known for his work in AI and biological discovery.

WHAT:

New York Times - AI drug design startup Chai Discovery raised $400 million led by Index at a $3.8 billion valuation.

Techmeme - Miles Wang is launching an AI drug discovery startup.

Techmeme - The startup is in talks to raise $200 million at a $2 billion valuation.

TechCrunch - The funding discussions indicate investor interest in applying AI to life sciences.

WHERE:

Techmeme - The location of the startup is not specified, but it is implied to be in the tech and life sciences sector.

WHEN:

Techmeme - The startup's funding discussions are ongoing, with no specific future date mentioned.

WHY:

TechCrunch - There is a growing investor interest in using AI for breakthroughs in life sciences.

HOW:

Techmeme - The startup aims to utilize AI for drug discovery and scientific advancements.

(UPDATED July 15, 2026 05:47 UTC)

Chai Discovery, an AI drug design startup, has successfully raised $400 million in funding, with Index leading the investment round. This funding brings the company's valuation to an impressive $3.8 billion. The news was reported by the New York Times at 03:56 UTC.

--

(UPDATED July 15, 2026 03:56 UTC)

Miles Wang, an OpenAI researcher known for his contributions to AI and biological discovery, is leaving the company to launch a new AI drug discovery startup. The startup is currently in discussions to raise $200 million at a valuation of $2 billion, reflecting a strong investor interest in applying AI to the life sciences sector. This venture aims to leverage AI for breakthroughs in drug discovery and scientific advancements, although the specific location of the startup has not been disclosed.